Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1078 | 1014 | 1103 | 1019 | 1139 | 1343 |
Fund Return | 7.81% | 1.38% | 10.26% | 0.62% | 2.64% | 2.99% |
Place in category | 287 | 400 | 357 | 111 | 107 | 40 |
% in Category | 49 | 68 | 64 | 24 | 27 | 22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0429081620 | 8.32B | 19.39 | 6.35 | - | ||
CH0429081638 | 8.32B | 12.98 | 5.65 | - | ||
CH0337393745 | 6.93B | 19.44 | 6.71 | - | ||
CSIF CH Emerging Markets Index Blue | 3.9B | 14.82 | -3.21 | 2.36 | ||
CH0017844686 | 3.9B | 14.74 | -3.29 | 2.28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UBS CH Vitainvest 50 World U | 4.4B | 2.45 | -0.62 | 2.66 | ||
Raiffeisen Pension Invest Futura Ba | 4.33B | 5.56 | -2.73 | 2.26 | ||
Raiffeisen Pension Invest Futura BI | 4.33B | 6.13 | -2.34 | 1.94 | ||
Julius Baer Institutional BVG LPPb1 | 3.89B | 6.52 | 0.92 | 3.34 | ||
Julius Baer Institutional BVG LPPB2 | 3.89B | 6.67 | 1.10 | 3.52 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UBS (Irl) plc - MSCI USA ESG Leaders UCITS USD A-a | IE00063GNWK1 | 9.42 | 223.40 | 0.00% | |
iShares Sust MSCI USA SRI | IE00BYVJRR92 | 4.25 | 15.742 | -0.19% | |
Nestle | CH0038863350 | 3.45 | 78.00 | -1.29% | |
Novartis | CH0012005267 | 2.92 | 92.36 | -0.78% | |
Roche Holding Participation | CH0012032048 | 2.64 | 262.50 | -1.13% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review